ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1130

Global DNA Methylation Analysis of Osteoarthritic Subchondral Bone Reveals Significant Regional Variation and Similarity to Overlying Cartilage

Matlock A. Jeffries1,2, Madison Andrews3, Mary Beth Humphrey1, Judith A. James4 and Amr H. Sawalha5, 1Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Association, Oklahoma City, OK, 3Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Univers, Oklahoma City, OK

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: DNA Methylation, Epigenetics, osteoarthritis and subchondral bone

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a leading cause of chronic disability affecting a majority of individuals over age 70. Outside of cartilage, little is known regarding changes in DNA methylation that occur regionally within OA joints. Herein, we performed global DNA methylation analysis of subchondral bone underlying eroded and intact regions of the OA hip joints and compared it to our previous analysis of OA cartilage.

Methods: Twelve femoral heads were obtained from hip arthroplasty for primary OA.  From eroded and intact areas of each joint, articular cartilage and 1cm-deep cores of underlying subchondral bone were dissected, frozen in liquid nitrogen, and DNA extracted.  Methylation profiling of >485,000 sites was performed using Illumina HumanMethylation450 arrays; differential methylation was defined as FDR-corrected p<0.01 with absolute methylation difference of at least 15%.  Pyrosequencing confirmed the four most differentially methylated sites.

Results: We identified 5477 hypo- and 1839 hypermethylated CpG sites in subchondral bone underlying eroded cartilage compared to intact tissue, corresponding to 2290 and 621 genes, respectively.  The most hypomethylated genes included the RISC component EIF2C2, ERGIc1, the cell adhesion molecule LPP, and the MAPK deactivator DUSP1, whereas the most hypermethylated genes were HOXA7, CD4, CD6, and CD28.  Pathway analysis revealed genes involved in cancer (n=96, p=1.38E-12), axonal guidance (n=104, p=4×10-11), NFAT signaling (n=55, p=4×10-10), and ERK/MAPK signaling (n=55, p=1×10-9).  The most highly associated upstream regulators included TGFβ1 (p=3×10-39), TNF (p=1×10-27), and p53 (p=8×10-24).  Comparing subchondral bone results to our OA cartilage data, 153 methylation sites from 420 genes were differentially methylated in both OA cartilage and subchondral bone.  Significant overlap in upstream regulators and many shared pathways were found including ERK/MAPK-, NFAT-, IGF-1-, and PTEN-signaling.  Among upstream regulators, TGFβ, miR-124, angiotensinogen, RANKL, and p38 MAPK were all highly associated with differentially methylated genes in both cartilage and subchondral bone.  Four previously-identified OA susceptibility genes, COL11A2, FTO, LRP5, and NCOR2, were differentially methylated in both subchondral bone and overlying cartilage.

Conclusion: Our data implicate epigenetic dysregulation of several genes and pathways in localized areas of subchondral bone underlying OA damage.  Although relatively few differentially methylated sites were shared among cartilage and subchondral bone, there was substantial overlap among pathways and upstream regulators.  Our work strengthens the notion that a dysregulated epigenome among subchondral bone and cartilage are intimately linked in the pathogenesis of OA, and reiterates that OA represents a disease of the entire joint organ.


Disclosure: M. A. Jeffries, None; M. Andrews, None; M. B. Humphrey, None; J. A. James, None; A. H. Sawalha, None.

To cite this abstract in AMA style:

Jeffries MA, Andrews M, Humphrey MB, James JA, Sawalha AH. Global DNA Methylation Analysis of Osteoarthritic Subchondral Bone Reveals Significant Regional Variation and Similarity to Overlying Cartilage [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/global-dna-methylation-analysis-of-osteoarthritic-subchondral-bone-reveals-significant-regional-variation-and-similarity-to-overlying-cartilage/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/global-dna-methylation-analysis-of-osteoarthritic-subchondral-bone-reveals-significant-regional-variation-and-similarity-to-overlying-cartilage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology